Global Amniotic Membrane Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Amniotic Membrane Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Amniotic membrane is the innermost layer of the placenta consisting of a thick basement membrane and an avascular stromal matrix. It can be used as a graft and as a dressing to facilitate ocular surface reconstruction and to promote healing.

Market Overview:

The latest research study on the global Amniotic Membrane market finds that the global Amniotic Membrane market reached a value of USD 829.57 million in 2022. It’s expected that the market will achieve USD 1704.34 million by 2028, exhibiting a CAGR of 12.75% during the forecast period.

The COVID-19 epidemic has become a universal test for all mankind. This is not only a short-term public health event, but will also have a long-term and profound impact on the medical industry.

In order to alleviate the spread of COVID-19, most elective surgeries have been drastically performed globally. In the short term, the reduced demand for amniotic membrane has led to a corresponding decrease in the company's operating income. As the epidemic has affected the entire industrial chain, the distribution of amniotic membranes has also encountered problems such as delivery delays.

At the same time, it has not been determined whether the amniotic membrane provided by COVID-19 infected persons carries COVID-19. Therefore, harvesting amniotic membrane during the COVID-19 epidemic is risky, and additional measures need to be taken to avoid infection.

Product quality control risks

Amniotic membrane products are medical implanted devices, which directly affect the health and safety of medical patients, and the product quality control requirements are strict. If the company fails to implement the management specifications of the internal quality control system, it will cause product quality problems, cause harm to product users, and lead to legal proceedings, which may have a significant impact on the company's operations.

The growth of the elderly population, the increase of eye surgery

Surgery performed with amniotic membrane in clinical practice includes amniotic membrane covering, amniotic membrane filling, amniotic membrane transplantation, epithelial cell transplantation and so on. In addition, in anti-glaucoma surgery, the amniotic membrane can prevent the formation of scars between the membrane flaps. Therefore, amniotic membrane is widely used in the treatment of corneal ulcers, glaucoma, and other ophthalmic diseases, and it is a very ideal material. Due to the increase in the global elderly population, the number of eye surgeries is increasing, which has caused a huge demand for amniotic membrane products.

Region Overview:

North America had the highest growth rate of all regions.

Company Overview:

MiMedx Group, Inc. is one of the major players operating in the Amniotic Membrane market, holding a share of 27.74% in 2020.

MiMedx Group, Inc.

MiMedx Group Inc. operates as a medical device company. The Company focuses on biomaterials for soft tissue repair, such as tendons, ligaments, and cartilage, as well as other biomaterial-based products for other medical applications. MiMedx Group serves the medical industry worldwide.

Integra LifeSciences Inc.

Integra Lifesciences Corporation manufactures devices used in neurosurgery and orthopedic surgery. The Company offers products such as devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair.

Segmentation Overview:

By type, Dehydrated Amniotic Membranes segment accounted for the largest share of market in 2021.

Cryopreserved Amniotic Membranes

Cryopreservation of AM involves slow freezing at 80C using DMEM/glycerol preservation media to allow for slow-rate freezing without ice formation. This preservation technique retains the extracellular matrix components, such as heavy-chain hyaluronic acids, growth factors, fibronectin, and collagen, all of which promote anti-inflammatory effects and healing. The tissue is stored in a 80C freezer and brought to room temperature when needed for use.

Dehydrated Amniotic Membranes

Dehydrated AM is preserved using vacuum with low temperature heat to retain devitalized cellular components. FDA-approved claims for this type of AM are limited to wound coverage. Unlike cryopreserved tissue, dehydrated AM is kept at room temperature, but it must be rehydrated for clinical use.

Application Overview:

By application, the Hospitals segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Amniotic Membrane market covered in Chapter 3:

Skye Biologics Inc.
Katena Products, Inc.
Integra LifeSciences Inc.
Applied Biologics LLC
MiMedx Group, Inc.
Organogenesis Holdings Inc
Amnio Technology, LLC
Osiris Therapeutics, Inc
Surgenex LLC

In Chapter 4 and Chapter 14.2, on the basis of types, the Amniotic Membrane market from 2018 to 2029 is primarily split into:

Cryopreserved Amniotic Membranes
Dehydrated Amniotic Membranes

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Amniotic Membrane market from 2018 to 2029 covers:

Hospitals
Specialized clinics
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)